Lalloo F - Search Results

1

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

Morgan RD, Burghel GJ, Flaum N, Bulman M, Smith P, Clamp AR, Hasan J, Mitchell CL, Salih Z, Woodward ER, Lalloo F, Crosbie EJ, Edmondson RJ, Schlecht H, Jayson GC, Evans DGR. Morgan RD, et al. Among authors: lalloo f. Cancers (Basel). 2023 Jan 25;15(3):730. doi: 10.3390/cancers15030730. Cancers (Basel). 2023. PMID: 36765687 Free PMC article.

2

An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.

Lalloo F, Cochrane S, Bulman B, Varley J, Elles R, Howell A, Evans DG. Lalloo F, et al. J Med Genet. 1998 Jan;35(1):10-2. doi: 10.1136/jmg.35.1.10. J Med Genet. 1998. PMID: 9475087 Free PMC article.

3

A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.

Lalloo F, Baildam A, Brain A, Hopwood P, Evans DG, Howell A. Lalloo F, et al. Eur J Surg Oncol. 2000 Nov;26(7):711-3. doi: 10.1053/ejso.2000.0986. Eur J Surg Oncol. 2000. PMID: 11078619

4

The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology.

Lalloo F, Evans DG. Lalloo F, et al. Breast Cancer Res. 1999;1(1):48-51. doi: 10.1186/bcr13. Epub 1999 Oct 27. Breast Cancer Res. 1999. PMID: 11250683 Free PMC article. Review.

5

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.

Lalloo F, Varley J, Ellis D, Moran A, O'Dair L, Pharoah P, Evans DG; Early Onset Breast Cancer Study Group. Lalloo F, et al. Lancet. 2003 Mar 29;361(9363):1101-2. doi: 10.1016/S0140-6736(03)12856-5. Lancet. 2003. PMID: 12672316

6

Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.

Evans DG, Bulman M, Young K, Gokhale D, Lalloo F. Evans DG, et al. Among authors: lalloo f. J Med Genet. 2003 Sep;40(9):e107. doi: 10.1136/jmg.40.9.e107. J Med Genet. 2003. PMID: 12960223 Free PMC article. No abstract available.

7

High detection rate for BRCA2 mutations in male breast cancer families from North West England.

Evans DG, Bulman M, Young K, Gokhale D, Lalloo F. Evans DG, et al. Among authors: lalloo f. Fam Cancer. 2001;1(3-4):131-3. doi: 10.1023/a:1021165031643. Fam Cancer. 2001. PMID: 14574168

8

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.

Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A. Amir E, et al. Among authors: lalloo f. J Med Genet. 2003 Nov;40(11):807-14. doi: 10.1136/jmg.40.11.807. J Med Genet. 2003. PMID: 14627668 Free PMC article.

9

Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families.

Evans DG, Neuhausen SL, Bulman M, Young K, Gokhale D, Lalloo F. Evans DG, et al. Among authors: lalloo f. J Med Genet. 2004 Feb;41(2):e21. doi: 10.1136/jmg.2003.012104. J Med Genet. 2004. PMID: 14757871 Free PMC article. No abstract available.

10

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.

Evans DG, Eccles DM, Rahman N, Young K, Bulman M, Amir E, Shenton A, Howell A, Lalloo F. Evans DG, et al. Among authors: lalloo f. J Med Genet. 2004 Jun;41(6):474-80. doi: 10.1136/jmg.2003.017996. J Med Genet. 2004. PMID: 15173236 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page